Maven Capital Partners has completed a £1.6 million investment in BioAscent Discovery Limited, an integrated drug discovery services business. The funding will enable BioAscent to significantly expand its service offering, adding complementary chemistry and biology services and capitalise on the growing trend towards the outsourcing of drug discovery activities. The funding will support the creation of 10 new jobs, including in highly skilled scientific positions, and fund additional laboratory space.